Summary
An animal model for testing substances that might prevent alopecia induced by oxazaphosphorines has been developed. It is based on the fact that the rat pups experience virtually total hair loss following administration of oxazaphosphorines. Using this model, we showed that epicutaneous treatment with sodium thioglycollate prevented ifosfamide-induced hair loss on the treated area. These experiments indicate that prevention of oxazaphosphorine-induced alopecia in man may be achieved by topical thiols.
References
Connors TA (1966) Protection against the toxicity of alkylating agents by thiols: The mechanism of protection and its relevance to cancer chemotherapy. Eur J Cancer 2:293
Garattini S, Palma V, Reyers-Degli Innocenti I, Guaitani A (1966) Effects of radioprotectors on damage induced by alkylating agents on tumoural and normal tissues. Eur J Cancer 2:237
Hill DL (1975) A review of cyclophosphamide. C. Thomas, Springfield, Illinois, p 176
Ishidate M, Sakurai Y, Yoshida T, Satoh H, Matsui E, Imamura H (1953) Studies on the toxicity of “Nitromin”. Interference of cysteine upon “Nitromin” toxicity. Jpn J Cancer Res 44:386
Powis G, Kooistra KL (1987) Doxorubicin-induced hair loss in the Angora rabbit: a study of treatment to protect against hair loss. Cancer Chemother Pharmacol 20:291
Seipp CA (1985) Adverse of treatment — hair loss. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology 2nd edn. Lippincot, Philadelphia, p 2007
Stekar J (1973) Teratogenicity of cyclophosphamides in newborn rats. Arzneimittelforschung 23:922
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stekar, J., Hilgard, P., Holtei, W. et al. Protection from ifosfamide-induced alopecia by topical thiols in young rats. Cancer Chemother. Pharmacol. 25, 306–307 (1990). https://doi.org/10.1007/BF00684892
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00684892